Suppr超能文献

The role of vascular endothelial growth inhibitor in wound healing.

作者信息

Conway Kevin P, Price Patricia, Harding Keith G, Jiang Wen G

机构信息

Metastasis and Angiogenesis Research Group, Department of Surgery, Cardiff University, College of Medicine, Cardiff, UK.

出版信息

Int Wound J. 2007 Mar;4(1):55-64. doi: 10.1111/j.1742-481X.2006.00295.x.

Abstract

Vascular endothelial growth inhibitor (VEGI) is an endothelial cell-specific cytokine and a potent inhibitor of endothelial cell proliferation and angiogenesis. The role of VEGI in angiogenesis related to tissue repair has previously not been investigated. Biopsies from different wound types were analysed by immunohistochemistry and quantitative polymerase chain reaction for the presence of VEGI protein and transcript, respectively. Human vascular endothelial cell line was transfected with VEGI expression plasmid and tested for their in vitro angiogenesis properties. Immunohistochemical staining for VEGI showed reduced expression in the dermal layer of the acute wounds compared with the chronic wound or normal skin. The ability of VEGI to prevent angiogenesis by in vitro assays showed that VEGI acts as a suppressor to the proliferation and microtubule formation of endothelial cells, and the addition of Hepatocyte Growth Factor had little effect on the ability of cell lines expressing the VEGI gene to increase microtubule formation. The aberrant expression of VEGI in different wound types appears to be linked to the outcome of the healing in these wounds. The altered expression of VEGI in chronic wounds constitutes an important target of future therapies.

摘要

相似文献

1
The role of vascular endothelial growth inhibitor in wound healing.
Int Wound J. 2007 Mar;4(1):55-64. doi: 10.1111/j.1742-481X.2006.00295.x.
2
Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis.
Semin Ophthalmol. 2006 Jan-Mar;21(1):49-58. doi: 10.1080/08820530500511446.
3
Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.
Int J Oncol. 2013 May;42(5):1664-73. doi: 10.3892/ijo.2013.1877. Epub 2013 Mar 29.
4
A novel secreted splice variant of vascular endothelial cell growth inhibitor.
FASEB J. 2002 May;16(7):742-4. doi: 10.1096/fj.01-0757fje. Epub 2002 Mar 26.

引用本文的文献

1
TNFSF15 facilitates the differentiation of CD11b myeloid cells into vascular pericytes in tumors.
Cancer Biol Med. 2023 Nov 2;20(11):869-84. doi: 10.20892/j.issn.2095-3941.2023.0245.
2
nWASP Inhibition Increases Wound Healing via TrKb/PLCγ Signalling.
Biomolecules. 2023 Feb 17;13(2):379. doi: 10.3390/biom13020379.
3
Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15.
Signal Transduct Target Ther. 2018 Aug 10;3:21. doi: 10.1038/s41392-018-0023-8. eCollection 2018.
4
Molecular and cellular impact of Psoriasin (S100A7) on the healing of human wounds.
Exp Ther Med. 2017 May;13(5):2151-2160. doi: 10.3892/etm.2017.4275. Epub 2017 Mar 28.
5
Vascular precursor cells in tissue injury repair.
Transl Res. 2017 Jun;184:77-100. doi: 10.1016/j.trsl.2017.02.002. Epub 2017 Feb 21.
7
TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.
Int J Mol Sci. 2016 Apr 25;17(5):615. doi: 10.3390/ijms17050615.
8
Tumour endothelial marker-8 in wound healing and its impact on the proliferation and migration of keratinocytes.
Int J Mol Med. 2016 Feb;37(2):293-8. doi: 10.3892/ijmm.2015.2434. Epub 2015 Dec 11.
9
TNFSF15 inhibits vasculogenesis by regulating relative levels of membrane-bound and soluble isoforms of VEGF receptor 1.
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13863-8. doi: 10.1073/pnas.1304529110. Epub 2013 Aug 5.

本文引用的文献

3
Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy.
Clin Cancer Res. 2005 Aug 15;11(16):6012-9. doi: 10.1158/1078-0432.CCR-05-0275.
6
Lymphangiogenesis quantification using quantitative PCR and breast cancer as a model.
Biochem Biophys Res Commun. 2001 Nov 9;288(4):1043-6. doi: 10.1006/bbrc.2001.5869.
9
Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily.
Int J Cancer. 1999 Jul 2;82(1):131-6. doi: 10.1002/(sici)1097-0215(19990702)82:1<131::aid-ijc22>3.0.co;2-o.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验